Evidence map›Paper›PMID 37214431›Full record

ArticleFrontiers in pharmacology2023

Metabolic markers of short and long-term exogenous DL-beta-hydroxybutyrate supplementation in episodic migraine patients: an exploratory analysis of a randomized-controlled-trial.

Niveditha Putananickal, Elena C Gross, Anna-Lena Orsini, Simone Schmidt, Patricia Hafner, Vanya Gocheva, Sara Nagy, Bettina C Henzi, Daniela Rubino, Sabine Schädelin and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Niveditha PutananickalDivision of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Basel, Switzerland.
Elena C GrossDivision of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Basel, Switzerland.
Anna-Lena OrsiniNeurology, University of Basel Hospital, University of Basel, Basel, Switzerland.
Simone SchmidtDivision of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Basel, Switzerland.
Patricia HafnerDivision of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Basel, Switzerland.
Vanya GochevaDivision of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Basel, Switzerland.
Sara NagyNeurology, University of Basel Hospital, University of Basel, Basel, Switzerland.
Bettina C HenziDivision of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Basel, Switzerland.
Daniela RubinoDivision of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Basel, Switzerland.
Sabine SchädelinDepartment of Clinical Research, Clinical Trial Unit, University of Basel Hospital, University of Basel, Basel, Switzerland.
Peter SandorRehaClinic, Bad Zurzach, Switzerland.
Dirk FischerDivision of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DL-Mg-Ca-beta-hydroxybutyrateexogenous ketone bodiesketone saltlong-term ketone supplementationmigraine

Identifiers

PMID37214431
PMCPMC10192563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.